In the evaluation of hormones, the hypospadias/CAVD group had higher FSH levels and lower testosterone than in the non-hypospadias/CAVD group (FSH: 7.28 ± 3.91 vs. 4.24 ± 1.96 IU/L, p = 0.027; T: 10.38 ± 2.45 vs. 12.92 ± 4.29 nmol/L, p = 0.192) (Table 1). The gene discussed is BRD2; the disease is hypospadias.